Bi et al28 showed the putative tumor‐suppressor role of MT1JP by negatively modulating the action of the Wnt/β‐catenin signaling pathway in the development of RB and that it may also be used as a prognostic biomarker and therapeutic target. Here, MT1JP is linked to retinoblastoma.